Cite

HARVARD Citation

    Koc, Ö. et al. (2021). Immunogenicity and safety of HBAI20 Hepatitis B vaccine in non‐responders: Double‐blinded, randomised, controlled phase 2 trial. Liver international. pp. 2318-2327. [Online]. 
  
Back to record